Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001654954-25-010100
Filing Date
2025-08-27
Accepted
2025-08-27 17:25:28
Documents
17

Document Format Files

Seq Description Document Type Size
1 424B5 cvm_424b5.htm 424B5 616281
2 cvm_s3img21.jpg GRAPHIC 49240
3 cvm_s3img20.jpg GRAPHIC 34603
4 cvm_s3img19.jpg GRAPHIC 52173
5 cvm_s3img18.jpg GRAPHIC 39663
6 cvm_s3img17.jpg GRAPHIC 22570
7 cvm_s3img16.jpg GRAPHIC 26907
8 cvm_s3img15.jpg GRAPHIC 26408
9 cvm_424b5img18.jpg GRAPHIC 6754
10 cvm_424b5img17.jpg GRAPHIC 41574
11 cvm_424b5img16.jpg GRAPHIC 42927
12 cvm_424b5img15.jpg GRAPHIC 42014
13 cvm_424b5img14.jpg GRAPHIC 33336
14 cvm_424b5img13.jpg GRAPHIC 17915
15 cvm_424b5img12.jpg GRAPHIC 31793
16 cvm_424b5img11.jpg GRAPHIC 31275
17 cvm_424b5img10.jpg GRAPHIC 4564
  Complete submission text file 0001654954-25-010100.txt   1312990
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-288515 | Film No.: 251266550
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)